Development of Drugs for Antimicrobial-Resistant Pathogens
Download Your Copy
We respect your privacy, by submitting this form you agree to having your details passed onto the sponsor who may promote similar products and services related to your area of interest. For further information on how we process and monitor your personal data click here.
Clinicians have noted an association between antimicrobial resistance and antimicrobial use since the introduction of these agents over 50 years ago. The problem of resistance becomes more pressing, however, when organisms acquire resistance mechanisms to multiple antimicrobial agents. Treatment options are limited for some multidrug-resistant organisms. Antimicrobial resistance is a driving force for the need for new antimicrobial agents, especially for these multidrug-resistant pathogens. At the same time, large pharmaceutical companies have indicated that they are devoting fewer resources to antimicrobial drug development.
To continue reading this story get free access
Please note: That all fields marked with an asterisk (*) are required.